Surge is thrilled to announce the formal launch of its globally commercialized microencapsulated APIs in the form of coated pellets for the domestic formulation industry at the upcoming 20th Pharma Asia event, scheduled to take place at the Karachi Expo Centre on November 14, 2023. The newly introduced Micorencapsulated APIs encompass a range of innovative pharmaceutical solutions, including:
- Dexlansoprazole Dual Delay Release Pellets for Capsules
- Tamsulosin Delayed Release Pellets
- Itraconazole Immediate Release Pellets
- Ciprofloxacin Base Taste Masked Coated Granules for Dry Syrup
- Mebeverine Delayed Release Pellets for Capsules
This significant development promises to bring cutting-edge pharmaceutical solutions to the forefront of the industry, further enhancing Surge’s commitment to innovation and excellence. Don’t miss the opportunity to explore these groundbreaking offerings at 20th Pharma Asia.